Yuxiao Zheng
Department Of PET CT
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
COP1 drives renal cell carcinoma progression by targeting ACSL4 for ubiquitin-mediated degradation and inhibiting ferroptosis.
Journal: Frontiers in oncology
Published: February 04, 2025
CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m6A-dependent manner.
Journal: Cellular and molecular life sciences : CMLS
Published: January 13, 2023
Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer.
Journal: Frontiers in immunology
Published: April 29, 2022
Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma.
Journal: Frontiers in oncology
Published: July 29, 2021
Incidence trends and survival outcomes of penile squamous cell carcinoma: evidence from the Surveillance, Epidemiology and End Results population-based data.
Journal: Annals of translational medicine
Published: December 14, 2020
Nomograms to predict overall and cancer-specific survival in patients with upper tract urothelial carcinoma: a large population-based study.
Journal: Translational andrology and urology
Published: July 18, 2020
Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
Journal: Annals of translational medicine
Published: April 21, 2020
Clinical characteristics and genetic testing of an atypical familial von Hippel-Lindauzon renal cell carcinoma.
Journal: Annals of translational medicine
Published: January 14, 2020
Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Journal: Annals of translational medicine
Published: December 07, 2019
Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.
Journal: Annals of translational medicine
Published: November 09, 2019
A new strategy for the treatment of sorafenib-refractory metastatic renal cell carcinoma in China: combination with intermittent chemotherapy.
Journal: Translational andrology and urology
Published: September 27, 2019
Last Updated: 09/26/2026